Advanced

Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening

Dell'Orco, Daniele; Lundqvist, Martin LU ; Cedervall, Tommy LU and Linse, Sara LU (2012) In Nanomedicine: Nanotechnology, Biology and Medicine 8(8). p.1271-1281
Abstract
Nanoparticles (NPs) for medical applications are often introduced into the body via intravenous injections, leading to the formation of a protein corona on their surface due to the interaction with blood plasma proteins. Depending on its composition and time evolution, the corona will modify the biological behavior of the particle. For successful delivery and targeting, it is therefore important to assess on a quantitative basis how and to what extent the presence of the corona perturbs the specific interaction of a designed NP with its cellular target. We present a theoretical systems-level analysis, in which peptides have been covalently coupled to the surface of nanoparticles, describing the delivery success rate in varying conditions,... (More)
Nanoparticles (NPs) for medical applications are often introduced into the body via intravenous injections, leading to the formation of a protein corona on their surface due to the interaction with blood plasma proteins. Depending on its composition and time evolution, the corona will modify the biological behavior of the particle. For successful delivery and targeting, it is therefore important to assess on a quantitative basis how and to what extent the presence of the corona perturbs the specific interaction of a designed NP with its cellular target. We present a theoretical systems-level analysis, in which peptides have been covalently coupled to the surface of nanoparticles, describing the delivery success rate in varying conditions, with regard to protein composition of the surrounding fluid. Dynamic modeling and parameter sensitivity analysis proved to be useful and computationally affordable tools to aid in the design of NPs with increased success rate probability in a biological context. FROM THE CLINICAL EDITOR: The formation of a protein corona consisting of blood plasma proteins on the surface of intravenously delivered nanoparticles may modify the biological behavior of the particles. This team of investigators present a theoretical systems-level analysis of this important and often neglected phenomenon. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nanomedicine: Nanotechnology, Biology and Medicine
volume
8
issue
8
pages
1271 - 1281
publisher
Elsevier
external identifiers
  • wos:000310428600005
  • scopus:84867864674
ISSN
1549-9642
DOI
10.1016/j.nano.2012.02.006
language
English
LU publication?
yes
id
780ac2dc-2649-4688-9c6c-356e9204eb49 (old id 3363005)
date added to LUP
2013-01-30 12:28:21
date last changed
2017-08-06 03:14:43
@article{780ac2dc-2649-4688-9c6c-356e9204eb49,
  abstract     = {Nanoparticles (NPs) for medical applications are often introduced into the body via intravenous injections, leading to the formation of a protein corona on their surface due to the interaction with blood plasma proteins. Depending on its composition and time evolution, the corona will modify the biological behavior of the particle. For successful delivery and targeting, it is therefore important to assess on a quantitative basis how and to what extent the presence of the corona perturbs the specific interaction of a designed NP with its cellular target. We present a theoretical systems-level analysis, in which peptides have been covalently coupled to the surface of nanoparticles, describing the delivery success rate in varying conditions, with regard to protein composition of the surrounding fluid. Dynamic modeling and parameter sensitivity analysis proved to be useful and computationally affordable tools to aid in the design of NPs with increased success rate probability in a biological context. FROM THE CLINICAL EDITOR: The formation of a protein corona consisting of blood plasma proteins on the surface of intravenously delivered nanoparticles may modify the biological behavior of the particles. This team of investigators present a theoretical systems-level analysis of this important and often neglected phenomenon.},
  author       = {Dell'Orco, Daniele and Lundqvist, Martin and Cedervall, Tommy and Linse, Sara},
  issn         = {1549-9642},
  language     = {eng},
  number       = {8},
  pages        = {1271--1281},
  publisher    = {Elsevier},
  series       = {Nanomedicine: Nanotechnology, Biology and Medicine},
  title        = {Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening},
  url          = {http://dx.doi.org/10.1016/j.nano.2012.02.006},
  volume       = {8},
  year         = {2012},
}